ALCOAST 289/08 COMDTNOTE 6230 SUBJ: SMOKING CESSATION UPDATE, WARNING AGAINST USE OF CHANTIX 1. ON 21 MAY 2008, THE INSTITUTE FOR SAFE MEDICATION PRACTICE (ISMP) RELEASED A REPORT ON SIDE EFFECTS AND ADVERSE SAFETY CONCERNS ASSOCIATED WITH CHANTIX (VARENICLINE). CHANTIX IS INCREASINGLY USED ACROSS THE COUNTRY AND WITHIN DOD AND THE COAST GUARD IN SMOKING CESSATION PROGRAMS. 2. THE ISMP REPORT INCLUDES THE FOLLOWING - THERE ARE IMMEDIATE SAFETY CONCERNS ABOUT THE USE OF CHANTIX AMONG PERSONS OPERATING AIRCRAFT, TRAINS, BUSES AND OTHER VEHICLES, OR IN OTHER SETTINGS WHERE A LAPSE IN ALERTNESS OR MOTOR CONTROL COULD LEAD TO MASSIVE, SERIOUS INJURY. OTHER EXAMPLES INCLUDE PERSONS OPERATING NUCLEAR POWER REACTORS, HIGH-RISE CONSTRUCTION CRANES OR LIFE-SUSTAINING MEDICAL DEVICES. BASED ON REPORTS OF SUDDEN LOSS OF CONSCIOUSNESS, SEIZURES, MUSCLE SPASMS, VISION DISTURBANCES, HALLUCINATIONS, PARANOIA AND PSYCHOSIS, CHANTIX MAY NOT BE SAFE TO USE IN THESE SETTINGS. THE EXTENT TO WHICH CHANTIX HAS ALREADY CONTRIBUTED TO ACCIDENTAL DEATH AND INJURY HAS NOT YET BEEN INVESTIGATED BECAUSE THESE ADVERSE EFFECTS HAD NOT BEEN PREVIOUSLY REPORTED. 3. THE SAFETY AND HEALTH OF OUR MEN AND WOMEN IN UNIFORM IS PARAMOUNT. ASSISTING WITH THEIR DESIRE TO STOP SMOKING IS IMPORTANT WHEREVER THEY ARE ASSIGNED AND WHATEVER THEIR MISSION IS. HOWEVER, ENSURING THAT MEDICATIONS PRESCRIBED DO NOT PUT THEM AND OTHERS AT INCREASED RISK OF INJURY OR DEATH IS ESSENTIAL. 4. COAST GUARD PERSONNEL WHO ARE CURRENTLY TAKING CHANTIX ARE STRONGLY ENCOURAGED TO STOP TAKING THE MEDICATION UNTIL FURTHER GUIDANCE FROM CG-11, AND SHOULD DISCUSS WITH THEIR HEALTH CARE PROVIDER APPROPRIATE TREATMENT ALTERNATIVES. 5. COAST GUARD PERSONNEL TAKING OR DISCONTINUING USE OF CHANTIX SHOULD IMMEDIATELY REPORT CHANGES IN MOOD AND BEHAVIOR TO THEIR HEALTH CARE PROVIDER. INDIVIDUALS TAKING CHANTIX MAY EXPERIENCE VIVID, UNUSUAL, OR STRANGE DREAMS AND MAY EXPERIENCE IMPAIRMENT OF THE ABILITY TO DRIVE OR OPERATE HEAVY MACHINERY. SYMPTOMS MAY INCLUDE ANXIETY, NERVOUSNESS, TENSION, DEPRESSED MOOD, UNUSUAL BEHAVIORS, AND THINKING ABOUT OR ATTEMPTING SUICIDE. 6. HEALTH CARE PROVIDERS AND COAST GUARD PERSONNEL SHALL BE ALERT TO, AND MONITOR FOR, CHANGES IN MOOD AND BEHAVIOR IN PERSONNEL TREATED WITH CHANTIX. IN MOST CASES THESE SYMPTOMS DEVELOP DURING CHANTIX TREATMENT, BUT SYMPTOMS MAY DEVELOP FOLLOWING WITHDRAWAL OF CHANTIX THERAPY. 7. COAST GUARD PERSONNEL CURRENTLY TAKING CHANTIX ARE STRONGLY ENCOURAGED TO CALL THE MAYO CLINIC TOBACCO QUIT (MCTQ) AT 1-888- 642-5566 FOR COUNSELING SUPPORT AND ALTERNATIVE SMOKING CESSATION THERAPIES. NICOTINE REPLACEMENT THERAPY (NRT) IS AVAILABLE FOR BENEFICIARIES AT COAST GUARD CLINICS AND THROUGH MCTQ AT NO COST TO ACTIVE DUTY MEMBERS AND THEIR DEPENDENTS, RESERVISTS ON ACTIVE DUTY AND CG CIVILIAN PERSONNEL. COMBINATION NRT (PATCHES, GUM, LOZENGES) HAS BEEN SHOWN TO BE HIGHLY EFFECTIVE IN TREATING NICOTINE DEPENDANCE AND MAY LESSON THE POTENTIAL SIDE EFFECTS OF ENDING CHANTIX USE. 8. COAST GUARD CIVILIAN PERSONNEL TAKING CHANTIX OR RECENTLY DISCONTINUING USE OF CHANTIX ARE STRONGLY RECOMMENDED TO CONTACT THEIR HEALTH CARE PROVIDER FOR ADDITIONAL INFORMATION. 9. COMMANDING OFFICERS/OFFICERS-IN-CHARGE SHALL ENSURE THAT ALL MEMBERS IN THEIR COMMAND ARE AWARE OF THIS ADVISORY. 10. FOR QUESTIONS REGARDING THIS MESSAGE, CONTACT CAPT BRENT PENNINGTON BRENT.PENNINGTON(AT)USCG.MIL OR (202) 475-5170 OR CAPT MARY FONG AT MARY.FONG(AT)USCG.MIL OR (202) 475-5181. 11. CAPT LORI A. MATHIEU, ACTING DIRECTOR OF HEALTH, SAFETY AND WORK-LIFE SENDS. 12. INTERNET RELEASE AUTHORIZED.